- Home
- NML vs ANGO Comparison
NML vs ANGO Comparison
Compare NML & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NML | ANGO |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.5M | 420.2M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | NML | ANGO |
|---|---|---|
| Price | $9.81 | $10.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 184.5K | ★ 496.7K |
| Earning Date | 01-01-0001 | 04-02-2026 |
| Dividend Yield | ★ 9.75% | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $7.89 | $8.36 |
| 52 Week High | $10.71 | $13.99 |
Technical Indicators
Market Signals| Indicator | NML | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 38.28 | 47.35 |
| Support Level | $9.65 | $9.62 |
| Resistance Level | $9.94 | $11.06 |
| Average True Range (ATR) | 0.24 | 0.59 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 12.57 | 38.01 |
Price Performance
Historical ComparisonAbout NML Neuberger Berman Energy Infrastructure and Income Fund Inc.
Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.